Publisher: Elsevier

Related content
Volume 25, Number 1, 3 May 1997

< previous issue | all issues | next issue >

Favourites:Add to Favourites

Differential relationships between positive and negative symptoms and neuropsychological deficits in schizophrenia
pp. 1-10(10)
Authors: Berman, I.; Viegner, B.; Merson, A.; Allan, E.; Pappas, D.; Green, A.I.

Favourites:Add to Favourites

Cerebral perfusion correlates of negative symptomatology and parkinsonism in a sample of treatment-refractory schizophrenics: an exploratory 99mTc-HMPAO SPET study
pp. 11-20(10)
Authors: Rodriguez, V.M.; Andree, R.M.; Castejon, M.J.P.; Labrador, R.G.; Navarrete, F.F.; delgado, J.L.C.; Vila, F.J.R.

Favourites:Add to Favourites

The functional significance of symptomatology and cognitive function in schizophrenia
pp. 21-31(11)
Authors: Velligan, D.I.; Mahurin, R.K.; Diamond, P.L.; Hazleton, B.C.; Eckert, S.L.; Miller, A.L.

Favourites:Add to Favourites

Non-selective impairment of Wisconsin Card Sorting Test performance in patients with schizophrenia
pp. 33-42(10)
Authors: Dieci, M.; Vita, A.; Silenzi, C.; Caputo, A.; Comazzi, M.; Ferrari, L.; Ghiringhelli, L.; Mezzetti, M.; Tenconi, F.; Invernizzi, G.

Favourites:Add to Favourites

Language processing and memory in ill and well siblings from multiplex families affected with schizophrenia
pp. 43-52(10)
Authors: Shedlack, K.; Lee, G.; Sakuma, M.; Xie, S.; Kushner, M.; Pepple, J.; Finer, D.L.; Hoff, A.L.; deLisi, L.E.

Favourites:Add to Favourites

Chronic haloperidol treatment does not affect structure of attention in schizophrenia
pp. 53-61(9)
Authors: Allen, D.N.; Gilbertson, M.W.; van Kammen, D.P.; Kelley, M.E.; Gurklis, J.A.; Barry, E.J.

Favourites:Add to Favourites

Metabolites of the antipsychotic agent clozapine inhibit the replication of human immunodeficiency virus type 1
pp. 63-70(8)
Authors: Jones-Brando, L.V.; Buthod, J.L.; Holland, L.E.; Yolken, R.H.; Torrey, E.F.

Favourites:Add to Favourites

Relationship between negative symptoms in chronic schizophrenia and neuroleptic dose, plasma levels and side effects
pp. 71-78(8)
Authors: Tugg, L.A.; desai, D.; Prendergast, P.; Remington, G.; Reed, K.; Zipursky, R.B.

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more